Percutaneous Neuromodulation on the Anterior Pain Knee

Neuromodulation Clinical Trial

Official title:

Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Anterior Pain Knee: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03883737
• Other study ID #: PNM and knee
• Status: Completed
• Phase: N/A
• Start date: April 14, 2019
• Est. completion date: November 1, 2019

Study information

• Verified date: July 2020
• Source: University of Seville
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Anterior knee pain (AKP) is one of the most frequent pathologies of the lower limb, in young and adult subjects. In the field of Physiotherapy, ultrasound-guided Percutaneous Neuromodulation (PNM) is defined as the application through a needle with ultrasound guidance of an electrical current at low or medium frequency, seeking a sensitive and / or motor response of a peripheral nerve in some point of its trajectory, or of a muscle in a motor point, with a therapeutic objective. The objective of this study is to analyze that the effect of PNM on the femoral nerve produces statistically significant changes in pain, joint range and knee functionality in patients with chronic AKP. Thirty subjects will be recruited, which will be divided into 2 groups: group 1 to which PNM will be applied to the femoral nerve of the pain knee; and group 2 to which PNM will be applied to the femoral nerve of the non-pain knee. The PNM intervention with NMP will consist in the single application of an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: November 1, 2019
• Est. primary completion date: April 15, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• chronic anterior knee pain >3 months

• older than 18 years-old

Exclusion Criteria:

• Surgical intervention in the intervention area

• Prosthesis or osteosynthesis in the intervention area

• Cardiac or tumoral diseases

• Coagulopathies

• Be under the effects of certain medications

• contraindication characteristic of the puncture

Related Conditions & MeSH terms

• Anterior Pain Knee
• Femoral Nerve
• Neuromodulation

Intervention

Other:
• PNM
an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)

Locations

Country	Name	City	State
Spain	University of Seville	Seville

Sponsors (1)

Lead Sponsor	Collaborator
University of Seville

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	visual analog scale (VAS) (0, no pain; 100, maximum pain).	pain	up to 1 week
Primary	range joint	goniometer	up to 1 week
Primary	VISA-p questionnaire (0, maximum pain; 100, no pain).	Functional pain	up to 1 week
Primary	Kujala questionnaire (0, maximum pain; 100, no pain).	Functional pain	up to 1 week

External Links

•   Related Info